CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
-
Narrated by:
-
By:
About this listen
Featuring perspectives from Dr Jeremy S Abramson and Dr Loretta J Nastoupil, including the following topics:
- Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (0:00)
- Potential Treatment Benefits of CAR T-Cell Therapy (13:31)
- Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome (28:13)
- Finding Information About CAR T-Cell Therapy; Clinical Trials (36:28)
- Financial Issues; Risk of Infection (42:02)
- Coping with Anxiety; Healing and Moving On (53:27)
CME information and select publications
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.